
Regeneron
North America, New York, United States, Tarrytown
Description
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
Investor Profile
Regeneron has backed more than 9 startups, with 1 new investments in the last 12 months alone. The firm has led 3 rounds, about 33% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Post Ipo Equity, Series C rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series B (22%)
- Post Ipo Equity (22%)
- Series C (22%)
- Series A (11%)
- Series G (11%)
- Corporate Round (11%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Biopharma
- Bioinformatics
- Cloud Computing
- Software
- Life Science
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Regeneron frequently co-invest with?
Which angels does Regeneron often collaborate with?
What are some of recent deals done by Regeneron?
Find More Investors Like Regeneron
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides









